BioXcel Therapeutics Announces Reverse Stock Split
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will effect a 1-for-16 reverse stock split of its common stock.
Here is why companies split their stocks and why it matters. Plus, upcoming stock splits from Southern Copper, cannabis ETFs, ...
Nvidia (NASDAQ: NVDA) and Lam Research (NASDAQ: LRCX) play important roles in the artificial intelligence (AI) supply chain.
(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...
Shareholders of Al-Jouf Mineral Water Bottling Co. will discuss reducing the stock’s nominal value from SAR 10 to SAR 0.5 ...
A largely under-the-radar stock-split stock remains an amazing value amid a pricey market, while another highflier appears to be in a bubble.
BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...
Netflix and Meta Platforms look particularly ripe for a stock split in 2025. Here’s what each of these two has in store for ...
Since Palantir's IPO, the company hasn't yet announced a stock split. For most of Palantir's stock market history, the shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback